NISA INVESTMENT ADVISORS, LLC

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 937615 ST. LOUIS, MO

Position in ORIC

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$27,464

-$14,473 QoQ

Shares Held

2,536

-23.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#152

of 179 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. ORIC ranks #119 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	56,455	$28,042,892
2	REGN	Regeneron Pharmaceuticals, Inc.	19,412	$12,104,158
3	TECH	BIO-TECHNE Corp	68,452	$4,836,133
4	INCY	Incyte Corp	26,479	$3,001,659
5	ALNY	Alnylam Pharmaceuticals, Inc.	9,139	$2,751,113
6	DFTX	Definium Therapeutics, Inc.	48,369	$2,275,277
7	PRAX	Praxis Precision Medicines, Inc.	6,111	$2,045,901
8	EXEL	Exelixis, Inc.	36,758	$2,000,002

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$27,464	2,536	-23.4%	Shares	Sole	2026-08-10
2026-03-31	$41,937	3,310	+37.3%	Shares	Sole	2026-04-30
2025-12-31	$19,713	2,410	-1.1%	Shares	Sole	2026-01-15
2025-09-30	$29,232	2,436	0.0%	Shares	Sole	2025-10-23
2025-06-30	$24,725	2,436	+17300.0%	Shares	Sole	2025-07-31
2025-03-31	$78	14	-93.4%	Shares	Sole	2025-04-30
2024-12-31	$1,710	212	+50.4%	Shares	Sole	2025-01-17
2024-09-30	$1,445	141	+107.4%	Shares	Sole	2024-10-24
2024-06-30	$480	68	+100.0%	Shares	Sole	2024-07-19
2024-03-31	$467	34	-99.8%	Shares	Sole	2024-05-02
2022-03-31	$85,974	16,100	+380.6%	Shares	Sole	2022-04-29
2021-09-30	$70,048	3,350	0.0%	Shares	Sole	2021-10-18
2021-06-30	$59,261	3,350	—	Shares	Sole	2021-08-06
No filing history on record for this holder in this stock.